There's certainly been increased turnover over the past few days. Maybe something is brewing? (some new formulations perhaps)
Printable View
There have been a few sales at 1.2c. Weird that they didn't come before the SPP so that you could top up at 1c.
I just sold a few today and now need to decide how many I want to buy back.
Given the price isn't significantly above 1c, I think only long term holders will be buying into the SPP, not those looking to make a quick buck as it could easily drop back down to 1c or even 0.9c. Thoughts?
...hi CJ. I for one will be taking up my full entitlement (1.5m=$15k). I only see upside with Bliss and at 1c they are ridiculously under-priced in my opinion.
I'm posting my cheque for $15k today to purchase another 1.5 million shares - I see only positive news to come over the next 12 months from BLT.
The company is raising up to $4.5million - more than any recent capital raising - and that indicates to me that they finally have a plan and will have the $$$ to commercialise K12 and M18.
I'm buoyed by the fact that Edinburgh Nominees are putting in more capital, plus BLT now has two new trade investors in APPL and NZPR Group who can help in the sales arena.
On the revenue front, sales for the first four months of this year equate to 48% of the total revenue for the 2013 year. Sales are still only at a low level but at least they're going the right way on the graph.
New products are being developed for Asian and European markets, including an animal health product for Japan. Pharmacy and web sales in NZ are also showing strong growth. Sinopharm, the largest pharmaceutical company in China, has been appointed to market BLT oral health products in China. All positive steps.
The company says successful implementation of its business strategies are expected to deliver profits in the foreseeable future.
I think the indicators are that we could well see a slow but steady upward trend in the SP over the next year unless a major announcement is made, then a decent spike is possible, though nothing like a PEB at this stage!
DISC: Hold several million BLT @ 1.37c average.
With BLT, I think there's always the possibility of a sharp spike. We've said it for years, but there is massive potential with this thing. The team have been eagerly soldiering away with the science, product development and regulatory approvals for years. With the new partners on board, I really do think we're at the cusp of the market penetration, sales growth and corresponding share-price re-rating that we've been patiently waiting for. Prices at around only $10m (and approx 1.2cps) it won't take much good news to send the price up.
We've all seen with PEB how a company can work away for years with a low share-price, then all of a sudden a couple of deals are signed and the share-price goes into the stratosphere. Granted, different companies with different prospects, but who knows where we'll end up. Profitability "in the foreseeable future" and quite impressive revenue growth forecasts in the recent Simmons appraisal document.
Disc: hold BLT and PEB, and supporting both SPP/rights issues.
Strategically timed announcement with the SPP closing this Friday??
https://www.nzx.com/companies/BLT/announcements/242953
Disc: hold a small amount and figuring out if/how much to top up.
Must be the PEB hype going around where everyone wants to get in quick before it does do a last minute ditch and spirals.